PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17079241-10	2007	Cefotaxime-mediated TLR2 activation was not observed in lag-phase transformants exposed to sub-lethal concentrations.	Cefotaxime	0-10	toll like receptor 2	Homo sapiens	20-24	
15190028-2	2004	The aim of this study was to compare the activation of human TLR2 pathways after exposure of S. pneumoniae to faropenem, cefotaxime and vancomycin.	Cefotaxime	121-131	toll like receptor 2	Homo sapiens	61-65	
15190028-8	2004	Early log MIC cefotaxime or faropenem-treated bacteria also enhanced TLR2 activation by 3-fold and 4-fold, respectively, when compared with untreated bacteria.	Cefotaxime	14-24	toll like receptor 2	Homo sapiens	69-73	
15190028-7	2004	RESULTS: Lag phase S. pneumoniae treated at sub-MIC (1/8 MIC) cefotaxime or faropenem induced 11-fold and 8-fold increases, respectively, in TLR2-mediated IL-8 promoter activity when compared with untreated bacteria.	Cefotaxime	62-72	toll like receptor 2	Homo sapiens	141-145